- Home
- HFFG vs ABOS Comparison
HFFG vs ABOS Comparison
Compare HFFG & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFFG
- ABOS
- Stock Information
- Founded
- HFFG N/A
- ABOS 1996
- Country
- HFFG United States
- ABOS United States
- Employees
- HFFG N/A
- ABOS N/A
- Industry
- HFFG Food Distributors
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- HFFG Consumer Discretionary
- ABOS Health Care
- Exchange
- HFFG Nasdaq
- ABOS Nasdaq
- Market Cap
- HFFG 162.4M
- ABOS 166.4M
- IPO Year
- HFFG N/A
- ABOS 2021
- Fundamental
- Price
- HFFG $3.70
- ABOS $2.58
- Analyst Decision
- HFFG
- ABOS Strong Buy
- Analyst Count
- HFFG 0
- ABOS 4
- Target Price
- HFFG N/A
- ABOS $9.00
- AVG Volume (30 Days)
- HFFG 35.2K
- ABOS 163.3K
- Earning Date
- HFFG 11-07-2024
- ABOS 11-11-2024
- Dividend Yield
- HFFG N/A
- ABOS N/A
- EPS Growth
- HFFG N/A
- ABOS N/A
- EPS
- HFFG 0.07
- ABOS N/A
- Revenue
- HFFG $1,160,322,000.00
- ABOS N/A
- Revenue This Year
- HFFG N/A
- ABOS N/A
- Revenue Next Year
- HFFG N/A
- ABOS N/A
- P/E Ratio
- HFFG $49.56
- ABOS N/A
- Revenue Growth
- HFFG N/A
- ABOS N/A
- 52 Week Low
- HFFG $2.46
- ABOS $1.81
- 52 Week High
- HFFG $5.91
- ABOS $5.09
- Technical
- Relative Strength Index (RSI)
- HFFG 58.21
- ABOS 49.10
- Support Level
- HFFG $3.38
- ABOS $2.44
- Resistance Level
- HFFG $3.64
- ABOS $2.65
- Average True Range (ATR)
- HFFG 0.20
- ABOS 0.16
- MACD
- HFFG 0.03
- ABOS 0.01
- Stochastic Oscillator
- HFFG 90.32
- ABOS 61.82
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The Company's business consists of one operating segment; HF Group, which operates solely in the United States. The Company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.